WO2023021472 - A PHARMACEUTICAL PLATFORM TECHNOLOGY FOR DRUG DISCOVERY AND CONSUMER HEALTH PRODUCT DEVELOPMENT
National phase entry:
Publication Number
WO/2023/021472
Publication Date
23.02.2023
International Application No.
PCT/IB2022/057780
International Filing Date
19.08.2022
Title **
[English]
A PHARMACEUTICAL PLATFORM TECHNOLOGY FOR DRUG DISCOVERY AND CONSUMER HEALTH PRODUCT DEVELOPMENT
[French]
TECHNOLOGIE DE PLATEFORME PHARMACEUTIQUE POUR LA DÉCOUVERTE DE MÉDICAMENTS ET LE DÉVELOPPEMENT DE PRODUITS DE SANTÉ DE CONSOMMATEURS
Applicants **
TAM, Yun Kau
SINOVEDA CANADA INC.
Inventors
TSENG, Chih-Yuan
BJORNDAHL, Trent
Priority Data
63/234,910
19.08.2021
US
63/234,917
19.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2450 | |
| EPO | Filing, Examination, Granting | 12992 | |
| Japan | Filing, Examination, Granting | 2100 | |
| South Korea | Filing, Examination, Granting | 2022 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
26,704
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
In one embodiment, the present invention describes a method for identifying an optimized natural medicine containing defined doses of active and contributing ingredients. In one embodiment, the method disclosed in the present invention develops compositions comprising cannabinoids for the treatment of hepatocellular carcinoma.[French]
Dans un mode de réalisation, la présente invention concerne un procédé d'identification d'un médicament naturel optimisé contenant des doses définies de principes actifs et de contribution. Dans un mode de réalisation, le procédé décrit dans la présente invention développe des compositions comprenant des cannabinoïdes pour le traitement du carcinome hépatocellulaire.